News

#: FDA set to approve third COVID-vaccine dose for those with weakened immune systems: report

Table of Contents

“#: FDA set to approve third COVID-vaccine dose for those with weakened immune systems: report”

The U.S. Food and Drug Administration is expected to authorize a third dose of the COVID-19 vaccine for those with weakened immune systems as soon as Thursday, the New York Times reported Wednesday night.

The emergency-use authorization would apply to both the Pfizer
PFE,
-3.90%
-BioNTech
BNTX,
-13.76%
and Moderna
MRNA,
-15.64%
vaccines, and would benefit those who have had organ transplants or certain immunodeficiencies, the Times reported.

The news came hours after a Canadian study found a third dose of Moderna’s vaccine substantially improved protections for organ-transplant recipients.

If the FDA gives the go-ahead, the Centers for Disease Control and Prevention is expected to grant its approval during a meeting Friday, the Times said.

The FDA is reportedly aiming to give full approval of the Pfizer COVID-19 vaccine by Labor Day, and health officials are studying whether fully vaccinated people should get a booster shot to bolster their protection in the months ahead.

Mike Murphy

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.